TY - JOUR
T1 - ATP inhibits the hydrosmotic effect of AVP in rabbit CCT
T2 - Evidence for a nucleotide P2u receptor
AU - Rouse, D.
AU - Leite, M.
AU - Suki, W. N.
N1 - Copyright:
Copyright 2004 Elsevier B.V., All rights reserved.
PY - 1994/12/1
Y1 - 1994/12/1
N2 - In rabbit renal cortical collecting tubule (CCT), perfused in vitro at 38°C, ATP in concentrations of 10-7 M and greater inhibits arginine vasopressin (AVP)-stimulated osmotic water permeability (Pf). The P1-purinergic receptor antagonist 8-phenyltheophylline did not attenuate the inhibitory action of ATP, and the poorly hydrolyzable ATP analogue, 5'-adenylylimidodiphosphate (AMP-PNP), mimicked the effect of ATP, arguing against an effect of ATP on a P1 receptor or the "P site." Purinergic receptor agonists inhibited AVP-stimulated Pf with the following rank order efficacy: ATP = ADP = UTP = AMP-PNP = α,β-methylene-ATP > 2-methylthio-ATP ≫ AMP > adenosine, consistent with the pharmacology of a "nucleotide" receptor subtype. Pertussis toxin pretreatment attenuated the action of 10-5 and 10-6 MATP; however, 10-4 MATP failed to inhibit the hydrosmotic action of forskolin or 8-bromoadeno-sine 3',5'-cyclic monophosphate. Pretreatment with the phosphodiesterase inhibitor RO20-1724 or indomethacin did not inhibit the action of ATP. Staurosporin and 3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester significantly attenuated the inhibition of Pf by lower concentrations of ATP. These data suggest that ATP activates nucleotide receptors on the CCT, mobilizing intracellular Ca2+, which inhibits the hydrosmotic action of AVP.
AB - In rabbit renal cortical collecting tubule (CCT), perfused in vitro at 38°C, ATP in concentrations of 10-7 M and greater inhibits arginine vasopressin (AVP)-stimulated osmotic water permeability (Pf). The P1-purinergic receptor antagonist 8-phenyltheophylline did not attenuate the inhibitory action of ATP, and the poorly hydrolyzable ATP analogue, 5'-adenylylimidodiphosphate (AMP-PNP), mimicked the effect of ATP, arguing against an effect of ATP on a P1 receptor or the "P site." Purinergic receptor agonists inhibited AVP-stimulated Pf with the following rank order efficacy: ATP = ADP = UTP = AMP-PNP = α,β-methylene-ATP > 2-methylthio-ATP ≫ AMP > adenosine, consistent with the pharmacology of a "nucleotide" receptor subtype. Pertussis toxin pretreatment attenuated the action of 10-5 and 10-6 MATP; however, 10-4 MATP failed to inhibit the hydrosmotic action of forskolin or 8-bromoadeno-sine 3',5'-cyclic monophosphate. Pretreatment with the phosphodiesterase inhibitor RO20-1724 or indomethacin did not inhibit the action of ATP. Staurosporin and 3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester significantly attenuated the inhibition of Pf by lower concentrations of ATP. These data suggest that ATP activates nucleotide receptors on the CCT, mobilizing intracellular Ca2+, which inhibits the hydrosmotic action of AVP.
KW - Adenylyl cyclase
KW - Arginine vasopressin
KW - Intracellular ionized calcium
KW - Pertussis toxin
KW - Prosta-glandins
KW - Protein kinase C
UR - http://www.scopus.com/inward/record.url?scp=0028017453&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028017453&partnerID=8YFLogxK
M3 - Article
C2 - 8067390
AN - SCOPUS:0027975301
SN - 0363-6127
VL - 267
SP - F289-F295
JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology
JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology
IS - 2 36-2
ER -